| 发明名称 |
Use of nitrogen substituted thalidomide analogs for the treatment of macular degenerator |
| 摘要 |
The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, nitrogen-substituted thalidomide analogs and di-substituted thalidomide analogs have been shown to inhibit angiogenesis. Importantly, these compounds can be administered orally.
|
| 申请公布号 |
US7153867(B2) |
申请公布日期 |
2006.12.26 |
| 申请号 |
US20020213294 |
申请日期 |
2002.08.06 |
| 申请人 |
CELGENE CORPORATION |
发明人 |
SHAH JAMSHED H.;CONNER BARRY P.;SWARTZ GLENN M.;HUNSUCKER KIMBERLY A.;ROUGAS JOHN;D'AMATO ROBERT J.;PRIBLUDA VICTOR;TRESTON ANTHONY |
| 分类号 |
A61K31/445;A61K31/4523;A61K31/454;A61P9/00;A61P27/02;C07D401/04 |
主分类号 |
A61K31/445 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
